Obacunone Promotes Functional Recovery After Spinal Cord Injury by Attenuating Neuroinflammation by Targeting the TLR4/MyD88/p38 MAPK Pathway
Drug Design, Development and Therapy · 2026-03 · Volume 20 · 1-18
DOI: 10.2147/dddt.s577707 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026-03. Verfasst von Wenhao Kuang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Spinal Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China. Hauptthemen laut MEDLINE: Spinal Cord Injuries, p38 Mitogen-Activated Protein Kinases, Limonins, Neuroinflammatory Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
Spinal cord injury (SCI) triggers a complex secondary injury process, among which inflammation and apoptosis are the key factors of nerve injury. Obacunone (Oba) is a natural limonoid that has demonstrated a variety of pharmacological effects, but its role in SCI remains unclear.
Methods
Network pharmacology and bioinformatics analysis were employed to predict the functions and mechanisms of Oba in SCI. Subsequently, in vivo validation was conducted in a mouse SCI model, with motor function recovery assessed using open field, footprint, and swimming tests. Spinal cord histomorphology was examined via hematoxylin and eosin (HE) staining and Nissl staining, while the anti‑inflammatory and anti‑apoptotic effects were evaluated by Western blot and immunofluorescence. To further elucidate the underlying mechanisms, a lipopolysaccharide (LPS)-induced inflammatory model in BV‑2 microglial cells was established to study the anti‑inflammatory mechanisms of Oba. Furthermore, a BV‑2/HT22 neuronal co‑culture system was constructed to investigate neuroprotective effects of Oba against apoptosis.
Results
In vivo, Oba treatment improved motor function, promoted neural repair, reduced inflammation and apoptosis. Correspondingly, Oba suppressed the expression of LPS-induced pro-inflammatory cytokines in BV-2 cells. In a microglia-neuron co-culture system, Oba protected HT22 neurons from microglia-mediated inflammatory apoptosis. Mechanistically, the anti‑inflammatory effects of Oba were mediated by inhibiting the activation of the TLR4/MyD88/p38 MAPK pathway.
Conclusion
This study identifies Oba as an effective compound that mitigates secondary injury by reducing inflammation and apoptosis and promotes nerve repair and functional recovery post-SCI, supporting its potential for further therapeutic development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Spinal Surgery, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong, People's Republic of China.
- Department of Spinal Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, People's Republic of China.
- Department of Orthopedics, The Third People's Hospital of Chengdu, Chengdu, Sichuan, People's Republic of China.
- Department of Spinal Surgery, Shantou Central Hospital, Shantou, Guangdong, People's Republic of China.
Zitieren
APA
Kuang, W., Zhang, M., Zhang, J., Huang, H., Chen, Q., Yu, C., Peng, B., Sun, W., Lin, J., Cheng, J., & Zhu, L. (2026). Obacunone Promotes Functional Recovery After Spinal Cord Injury by Attenuating Neuroinflammation by Targeting the TLR4/MyD88/p38 MAPK Pathway. Drug Design, Development and Therapy, Volume 20, 1-18. https://doi.org/10.2147/dddt.s577707
Vancouver
Kuang W, Zhang M, Zhang J, Huang H, Chen Q, Yu C, et al. Obacunone Promotes Functional Recovery After Spinal Cord Injury by Attenuating Neuroinflammation by Targeting the TLR4/MyD88/p38 MAPK Pathway. Drug Design, Development and Therapy. 2026;Volume 20:1-18. doi:10.2147/dddt.s577707
BibTeX
@article{Kuang2026,
author = {Kuang, Wenhao and Zhang, Mi and Zhang, Jiaqi and Huang, Haoran and Chen, Qifan and Yu, Cheng and Peng, Birong and Sun, Wei and Lin, Jiezhao and Cheng, Junjie and Zhu, Lixin},
title = {Obacunone Promotes Functional Recovery After Spinal Cord Injury by Attenuating Neuroinflammation by Targeting the TLR4/MyD88/p38 MAPK Pathway},
journal = {Drug Design, Development and Therapy},
year = {2026},
volume = {Volume 20},
pages = {1--18},
doi = {10.2147/dddt.s577707}
}
EUVIMED